Literature DB >> 16391800

Chromosomal organization and fluorescence in situ hybridization of the human Sirtuin 6 gene.

Ulrich Mahlknecht1, Anthony D Ho, Susanne Voelter-Mahlknecht.   

Abstract

Sirtuin 6 (SIRT6) is a member of the sirtuin deacetylases (sirtuins), which are derivatives of the yeast Silent information regulator 2 (Sir2) protein. SIR2 and its mammalian derivatives play a central role in epigenetic gene silencing, recombination, metabolism, cell differentiation and in the regulation of aging. In contrast to most sirtuins, SIRT6 lacks NAD+-dependent protein deacetylase activity. We have isolated and characterized the human Sirt6 genomic sequence, which spans a region of 8,427 bp and which has one single genomic locus. Determination of the exon-intron splice junctions found the full-length SIRT6 protein to consist of 8 exons ranging in size from 60 bp (exon 4) to 838 bp (exon 8). The human Sirt6 open reading frame encodes a 355-aa protein with a predictive molecular weight of 39.1 kDa and an isoelectric point of 9.12. Characterization of the 5' flanking genomic region, which precedes the Sirt6 open reading frame, revealed a TATA- and CCAAT-box less promoter with an approximately 300-bp long CpG island. A number of AML-1 and GATA-x transcription factor binding sites were found which remain to be further evaluated experimentally. Fluorescence in situ hybridization analysis localized the human Sirt6 gene to chromosome 19p13.3; a region which is frequently affected by chromosomal alterations in acute leukemia. Human SIRT6 appears to be most predominantly expressed in bone cells and in the ovaries while, in the bone marrow, it is practically absent. The functional characteristics of SIRT6 are essentially unknown at present and remain to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16391800

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  18 in total

Review 1.  Sirtuin activators and inhibitors.

Authors:  José M Villalba; Francisco J Alcaín
Journal:  Biofactors       Date:  2012-06-25       Impact factor: 6.113

Review 2.  Chromatin regulation and genome maintenance by mammalian SIRT6.

Authors:  Ruth I Tennen; Katrin F Chua
Journal:  Trends Biochem Sci       Date:  2010-08-21       Impact factor: 13.807

3.  The dual role of sirtuins in cancer.

Authors:  Laia Bosch-Presegué; Alejandro Vaquero
Journal:  Genes Cancer       Date:  2011-06

4.  Downregulation of SIRT6 is associated with poor prognosis in patients with non-small cell lung cancer.

Authors:  Bojin Zhu; Yongjin Yan; Boyun Shao; Luwen Tian; Weihua Zhou
Journal:  J Int Med Res       Date:  2018-01-24       Impact factor: 1.671

5.  SIRT6 overexpression induces massive apoptosis in cancer cells but not in normal cells.

Authors:  Michael Van Meter; Zhiyong Mao; Vera Gorbunova; Andrei Seluanov
Journal:  Cell Cycle       Date:  2011-09-15       Impact factor: 4.534

Review 6.  SIRT3 and cancer: tumor promoter or suppressor?

Authors:  Turki Y Alhazzazi; Pachiyappan Kamarajan; Eric Verdin; Yvonne L Kapila
Journal:  Biochim Biophys Acta       Date:  2011-05-07

7.  The RUNX2 Transcription Factor Negatively Regulates SIRT6 Expression to Alter Glucose Metabolism in Breast Cancer Cells.

Authors:  Moran Choe; Jessica L Brusgard; Saranya Chumsri; Lekhana Bhandary; Xianfeng Frank Zhao; Song Lu; Olga G Goloubeva; Brian M Polster; Gary M Fiskum; Geoffrey D Girnun; Myoung Sook Kim; Antonino Passaniti
Journal:  J Cell Biochem       Date:  2015-10       Impact factor: 4.429

8.  Changes in human sirtuin 6 gene promoter methylation during aging.

Authors:  Kaniye Sahin; Sibel Yilmaz; Nermin Gozukirmizi
Journal:  Biomed Rep       Date:  2014-03-31

9.  The sirtuins in the pathogenesis of cancer.

Authors:  Susanne Voelter-Mahlknecht; Ulrich Mahlknecht
Journal:  Clin Epigenetics       Date:  2010-08-20       Impact factor: 6.551

10.  Sirtuins, metabolism, and cancer.

Authors:  Barbara Martinez-Pastor; Raul Mostoslavsky
Journal:  Front Pharmacol       Date:  2012-02-21       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.